Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peter Harris
Mayo Clinic Rochester, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
GlaxoSmithKline
Other : Total IP royalties, through Mayo Clinic
Please see attached.
ADPKD: Disease Spectrum & Genotype-Phenotype Correlations
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited kidney disease in which the majority of affected individuals develop renal failure, requiring dialysis or renal transplant during their adult life. Many different mutations t two different genes are known to cause the disease and have correlations between mutations and the severity and presentations of the disease in the patient population. Genetic variants in other genes will also be sought as novel causes of ADPKD or modifiers of the disease course. These studies will help understand the causes of the disease, suggesting new treatments, be of diagnostic and prognostic value, and identify a population that will gain most from treatment.
Filed on September 12, 2017.
Tell us what you know about Peter Harris's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Peter Harris filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peter Harris | Mayo Clinic Rochester | Conflict of Interest | Bayer AG | $5,000 - $9,999 |
| Peter Harris | Mayo Clinic Rochester | Conflict of Interest | Vertex Pharmaceuticals | $5,000 - $9,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.